Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Oct 24;5(11):940-942.
doi: 10.1016/j.jdcr.2019.09.004. eCollection 2019 Nov.

A case of concurrent systemic sclerosis and scleredema

Drew C Mitchell  1 , Ritesh Agnihothri  2 , Glynis A Scott  2   3 , Benjamin Korman  4 , Christopher T Richardson  2   4
Affiliations
Case Reports

A case of concurrent systemic sclerosis and scleredema

Drew C Mitchell et al. JAAD Case Rep. .
No abstract available

Keywords: AI, antibody index; SAB, scleredema adultorum of Buschke; SSc, systemic sclerosis; scleredema; scleredema adultorum of Buschke; scleroderma; scleroderma mimics; sclerosing skin disease; systemic sclerosis; systemic sclerosis sine scleroderma.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Samples from biopsy of the upper portion of the back (original magnification ×20) show (A) thickened dermal collagen without inflammation and (B) subcutis displacement without destruction or fibrosis. (C) Alcian blue stain highlights increased dermal mucin. Original magnification, ×200.
See this image and copyright information in PMC

References

    1. Ferreli C., Gasparini G., Parodi A., Cozzani E., Rongioletti F., Atzori L. Cutaneous manifestations of scleroderma and scleroderma-like disorders: a comprehensive review. Clin Rev Allergy Immunol. 2017;53(3):306–336. - PubMed
    1. Knobler R., Moinzadeh P., Hunzelmann N. European Dermatology Forum S1—guideline on the diagnosis and treatment of sclerosing diseases of the skin, part 1: localized scleroderma, systemic sclerosis and overlap syndromes. J Eur Acad Dermatol Venereol. 2017;31(9):1401–1424. - PubMed
    1. Eckes B., Wang F., Moinzadeh P., Hunzelmann N., Krieg T. Pathophysiological mechanisms in sclerosing skin diseases. Front Med. 2017;4:120. - PMC - PubMed
    1. Knobler R., Moinzadeh P., Hunzelmann N. European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, part 2: scleromyxedema, scleredema and nephrogenic systemic fibrosis. J Eur Acad Dermatol Venereol. 2017;31(10):1581–1594. - PubMed
    1. Sharma A. Scleroderma-like disorders. Curr Rheumatol Rev. 2018;14(1):22–27. - PubMed

Publication types

LinkOut - more resources